Consideration of combination therapy with both vorinostat and ultraviolet therapy for cutaneous T-cell lymphoma patients
Not Applicable
- Conditions
- Cutaneous T-cell lymphoma, Mycosis fungoides, Sezary's syndrome
- Registration Number
- JPRN-UMIN000010590
- Lead Sponsor
- Department of Dermatology, Okayama University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who have treated with vorinostat 2)During treatment with systemic steroid 3)During treatment with retinoids 4)Carrier of HBV, HCV, HIV and so on 5)Patients who have severe comorbidity 6)During treatment with anti-cancer agents 7)Female who are pregnant or nursing, male hope to impregnate 8)Patients who have past history of severe allergy for vorinostat 9)Patients who are judged inappropriate to be enrolled in this study by the doctor in charge.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Feasibility
- Secondary Outcome Measures
Name Time Method Safety Response rate Alleviation of itch